Table of Contents
International Journal of Proteomics
Volume 2013, Article ID 701247, 8 pages
http://dx.doi.org/10.1155/2013/701247
Review Article

Protein Target Quantification Decision Tree

Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Drive, MS 4053, Indianapolis, IN 46202, USA

Received 15 October 2012; Revised 10 December 2012; Accepted 18 December 2012

Academic Editor: Vladimir Uversky

Copyright © 2013 Jong Won Kim and Jinsam You. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Westont and L. Hood, “Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine,” Journal of Proteome Research, vol. 3, no. 2, pp. 179–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. T. E. Angel, U. K. Aryal, S. M. Hengel et al., “Mass spectrometry-based proteomics: existing capabilities and future directions,” Chemical Society Reviews, vol. 41, pp. 3912–3928, 2012. View at Publisher · View at Google Scholar
  3. E. S. Boja and H. Rodriguez, “Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins,” Proteomics, vol. 12, pp. 1093–1110, 2012. View at Publisher · View at Google Scholar
  4. J. R. Whiteaker, C. Lin, J. Kennedy et al., “A targeted proteomics-based pipeline for verification of biomarkers in plasma,” Nature Biotechnology, vol. 29, no. 7, pp. 625–634, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. V. M. Faca, “Human mesenchymal stromal cell proteomics: contribution for identification of new markers and targets for medicine intervention,” Expert Review of Proteomics, vol. 9, pp. 217–230, 2012. View at Publisher · View at Google Scholar
  6. S. Jacquet, X. Yin, P. Sicard et al., “Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis,” Molecular and Cellular Proteomics, vol. 8, no. 12, pp. 2687–2699, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. V. G. Edwards, M. Y. White, and S. J. Cordwell, “The role of proteomics in clinical cardiovascular biomarker discovery,” Molecular and Cellular Proteomics, vol. 7, no. 10, pp. 1824–1837, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Sabel, “Surgical considerations in early-stage breast cancer: lessons learned and future directions,” Seminars in Radiation Oncology, vol. 21, no. 1, pp. 10–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. S. Sabel, Y. Liu, and D. M. Lubman, “Proteomics in melanoma biomarker discovery: great potential, many obstacles,” International Journal of Proteomics, vol. 2011, Article ID 181890, 8 pages, 2011. View at Publisher · View at Google Scholar
  10. T. D. Veenstra, “Proteomics research in breast cancer: balancing discovery and hypothesis-driven studies,” Expert Review of Proteomics, vol. 8, no. 2, pp. 139–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. J. Issaq, T. J. Waybright, and T. D. Veenstra, “Cancer biomarker discovery: opportunities and pitfalls in analytical methods,” Electrophoresis, vol. 32, no. 9, pp. 967–975, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Meng and T. D. Veenstra, “Targeted mass spectrometry approaches for protein biomarker verification,” Journal of Proteomics, vol. 74, pp. 2650–2659, 2011. View at Publisher · View at Google Scholar
  13. C. Prakash, C. L. Shaffer, L. M. Tremaine et al., “Application of liquid chromatography-accelerator mass spectrometry (LC-AMS) to evaluate the metabolic profiles of a drug candidate in human urine and plasma,” Drug Metabolism Letters, vol. 1, no. 3, pp. 226–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Carrascal, K. Schneider, R. E. Calaf et al., “Quantitative electrospray LC-MS and LC-MS/MS in biomedicine,” Journal of Pharmaceutical and Biomedical Analysis, vol. 17, no. 6-7, pp. 1129–1138, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. A. James and C. Jorgensen, “Basic design of MRM assays for peptide quantification,” Methods in Molecular Biology, vol. 658, pp. 167–185, 2010. View at Google Scholar · View at Scopus
  16. B. Han and R. E. Higgs, “Proteomics: from hypothesis to quantitative assay on a single platform. Guidelines for developing MRM assays using ion trap mass spectrometers,” Briefings in Functional Genomics and Proteomics, vol. 7, no. 5, pp. 340–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Q. Xia, S. T. Wu, and M. Jemal, “LC-FAIMS-MS/MS for quantification of a peptide in plasma and evaluation of FAIMS global selectivity from plasma components,” Analytical Chemistry, vol. 80, no. 18, pp. 7137–7143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Hossain, D. T. Kaleta, E. W. Robinson et al., “Enhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface,” Molecular and Cellular Proteomics, vol. 10, no. 2, pp. M000062–MCP201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Fortin, A. Salvador, J. P. Charrier et al., “Multiple reaction monitoring cubed for protein quantification at the low nanogram/milliliter level in nondepleted human serum,” Analytical Chemistry, vol. 81, no. 22, pp. 9343–9352, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. M. Lequin, “Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA),” Clinical Chemistry, vol. 51, no. 12, pp. 2415–2418, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. http://www.fda.gov/downloads/Drugs/.../Guidances/ucm070107.pdf.
  22. N. L. Anderson, “The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum,” Clinical Chemistry, vol. 56, no. 2, pp. 177–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. P. Ekins, “Multi-analyte immunoassay,” Journal of Pharmaceutical and Biomedical Analysis, vol. 7, no. 2, pp. 155–168, 1989. View at Google Scholar · View at Scopus
  24. W. de Jager and G. T. Rijkers, “Solid-phase and bead-based cytokine immunoassay: a comparison,” Methods, vol. 38, no. 4, pp. 294–303, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. G. Oliver, J. R. Kettman, and R. J. Fulton, “Multiplexed analysis of human cytokines by use of the flowmetrix system,” Clinical Chemistry, vol. 44, no. 9, pp. 2057–2060, 1998. View at Google Scholar · View at Scopus
  26. Q. Fu, J. Zhu, and J. E. van Eyk, “Comparison of multiplex immunoassay platforms,” Clinical Chemistry, vol. 56, no. 2, pp. 314–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. F. S. Apple and A. S. Jaffe, “Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study,” Circulation, vol. 104, no. 22, pp. E125–126, 2001. View at Google Scholar · View at Scopus
  28. A. S. Jaffe, “New standard for the diagnosis of acute myocardial infarction,” Cardiology in Review, vol. 9, no. 6, pp. 318–322, 2001. View at Google Scholar · View at Scopus
  29. M. Hartmann, J. Roeraade, D. Stoll, M. F. Templin, and T. O. Joos, “Protein microarrays for diagnostic assays,” Analytical and Bioanalytical Chemistry, vol. 393, no. 5, pp. 1407–1416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Gantelius, M. Hartmann, J. M. Schwenk, J. Roeraade, H. Andersson-Svahn, and T. O. Joos, “Magnetic bead-based detection of autoimmune responses using protein microarrays,” New Biotechnology, vol. 26, no. 6, pp. 269–276, 2009. View at Google Scholar · View at Scopus
  31. C. A. Spencer, M. Takeuchi, M. Kazarosyan et al., “Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 4, pp. 1121–1127, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. E. E. Niederkofler, U. A. Kiernan, J. O'Rear et al., “Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure,” Circulation, vol. 1, no. 4, pp. 258–264, 2008. View at Google Scholar · View at Scopus
  33. N. L. Anderson, N. G. Anderson, L. R. Haines, D. B. Hardie, R. W. Olafson, and T. W. Pearson, “Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA),” Journal of Proteome Research, vol. 3, no. 2, pp. 235–244, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. A. N. Hoofnagle, J. O. Becker, M. H. Wener, and J. W. Heinecke, “Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry,” Clinical Chemistry, vol. 54, no. 11, pp. 1796–1804, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. F. Lopez, T. Rezai, D. A. Sarracino et al., “Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants,” Clinical Chemistry, vol. 56, no. 2, pp. 281–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. N. L. Anderson, N. G. Anderson, T. W. Pearson et al., “A human proteome detection and quantitation project,” Molecular and Cellular Proteomics, vol. 8, no. 5, pp. 883–886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Anderson and C. L. Hunter, “Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins,” Molecular and Cellular Proteomics, vol. 5, no. 4, pp. 573–588, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Domanski, D. S. Smith, C. A. Miller et al., “High-flow multiplexed MRM-based analysis of proteins in human plasma without depletion or enrichment,” Clinics in Laboratory Medicine, vol. 31, pp. 371–384, 2011. View at Publisher · View at Google Scholar
  39. N. L. Anderson and N. G. Anderson, “The human plasma proteome: history, character, and diagnostic prospects,” Molecular & Cellular Proteomics, vol. 1, no. 11, pp. 845–867, 2002. View at Google Scholar · View at Scopus
  40. T. Shi, J. Y. Zhou, M. A. Gritsenko et al., “IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery,” Methods, vol. 56, pp. 246–253, 2012. View at Publisher · View at Google Scholar
  41. M. J. Berna, Y. Zhen, D. E. Watson, J. E. Hale, and B. L. Ackermann, “Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis,” Analytical Chemistry, vol. 79, no. 11, pp. 4199–4205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. J. A. Gutierrez, P. J. Solenberg, D. R. Perkins et al., “Ghrelin octanoylation mediated by an orphan lipid transferase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 17, pp. 6320–6325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. N. L. Anderson, A. Jackson, D. Smith, D. Hardie, C. Borchers, and T. W. Pearson, “SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device,” Molecular and Cellular Proteomics, vol. 8, no. 5, pp. 995–1005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Wolf-Yadlin, S. Hautaniemi, D. A. Lauffenburger, and F. M. White, “Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 14, pp. 5860–5865, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Drogaris, V. Villeneuve, C. Pomies et al., “Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation,” Scientific Reports, vol. 2, p. 220, 2012. View at Google Scholar
  46. Y. H. Ahn, P. M. Shin, N. R. Oh, G. W. Parka, H. Kimb, and J. S. Yoo, “A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma,” Journal of Proteomics, vol. 75, pp. 5507–5515, 2012. View at Publisher · View at Google Scholar
  47. H. Zhang, X. J. Li, D. B. Martin, and R. Aebersold, “Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry,” Nature Biotechnology, vol. 21, no. 6, pp. 660–666, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Sun, J. A. Ranish, A. G. Utleg et al., “Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics,” Molecular and Cellular Proteomics, vol. 6, no. 1, pp. 141–149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. H. John, M. Walden, S. Schäfer, S. Genz, and W. G. Forssmann, “Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography-mass spectrometry,” Analytical and Bioanalytical Chemistry, vol. 378, no. 4, pp. 883–897, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. B. Han, M. Copeland, A. G. Geiser et al., “Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity,” Journal of Proteome Research, vol. 6, no. 11, pp. 4218–4229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Keshishian, T. Addona, M. Burgess, E. Kuhn, and S. A. Carr, “Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution,” Molecular and Cellular Proteomics, vol. 6, no. 12, pp. 2212–2229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Gilar, P. Olivova, A. E. Daly, and J. C. Gebler, “Two-dimensional separation of peptides using RP-RP-HPLC system with different pH in first and second separation dimensions,” Journal of Separation Science, vol. 28, no. 14, pp. 1694–1703, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. L. V. DeSouza, A. D. Romaschin, T. J. Colgan, and K. W. M. Siu, “Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer,” Analytical Chemistry, vol. 81, no. 9, pp. 3462–3470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. S. J. Shah, K. H. Yu, V. Sangar, S. I. Parry, and I. A. Blair, “Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry,” Journal of Proteome Research, vol. 8, no. 5, pp. 2407–2417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Shi, T. L. Fillmore, X. Sun et al., “Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, pp. 15395–15400, 2012. View at Google Scholar
  56. C. S. Ang and E. C. Nice, “Targeted in-gel MRM: a hypothesis driven approach for colorectal cancer biomarker discovery in human feces,” Journal of Proteome Research, vol. 9, no. 9, pp. 4346–4355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. P. J. Halvey, C. R. Ferrone, and D. C. Liebler, “GeLC-MRM quantitation of mutant KRAS oncoprotein in complex biological samples,” Journal of Proteome Research, vol. 11, pp. 3908–3913, 2012. View at Publisher · View at Google Scholar
  58. N. Rifai, M. A. Gillette, and S. A. Carr, “Protein biomarker discovery and validation: the long and uncertain path to clinical utility,” Nature Biotechnology, vol. 24, no. 8, pp. 971–983, 2006. View at Publisher · View at Google Scholar · View at Scopus